Launch Version of Equashield's CSTD-Enabled Automated Pharmacy Compounding System to be Showcased at ASHP Midyear Meeting

Tuesday, November 27, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

Award-winning hazardous drug compounding system, Equashield Pro, will demo at American Society of Health System Pharmacy (ASHP) Midyear Meeting in Anaheim, CA

PORT WASHINGTON, New York, Nov. 27, 2018 /PRNewswire/ -- Equashield (equashield.com), a leading provider of Closed

System Transfer Devices (CSTDs) for hazardous drugs, today announced it will demonstrate the launch version of its CSTD-enabled Equashield® Pro Robot at the upcoming ASHP Midyear Meeting.

Equashield Pro is an Automated Pharmacy Compounding System for the safe and efficient preparation of injectable drugs, including hazardous drugs. The system, which utilizes Equashield's flagship CSTD, follows a multi-station compounding method, similar to a manufacturing production line, to minimize time and motion in dosage preparation.

Eight work stations provide a high throughput of up to 60 doses per hour to meet peak-time compounding needs. The Pro's versatility enables it to access all sized drug vials to process a wide range of finished product dosage forms, and its proprietary dose verification system prevents medication errors. Approximately the size of a standard Biological Safety Cabinet, the Equashield Pro facilitates the simple and cost-effective adoption of robotics in hospital pharmacies without the need for costly renovations and maintenance.

"Development of the Equashield Pro focused on three essential criteria: utilizing Equashield's flagship CSTD for extra protection during the hazardous drug compounding process; increasing productivity exponentially; and control of medication errors" said Gonen Daskal, Project Manager and System Architect for the Equashield Pro. "Focusing on these needs ensures that the Equashield Pro is not only ergonomic and innovative, but also provides the safest hazardous drug compounding environment for pharmacists."

The Equashield Pro was selected a Gold Winner in this year's Medical Design Excellence Awards in New York, the medical technology industry's premier design competition. It was also recognized as a "Best of the Best" winner of the Red Dot Award: Product Design 2018 in Germany and cited by the IDEA 2018 International Design Excellence Awards.

Equashield® Pro will be on display at the ASHP Midyear Meeting in Anaheim, CA, December 2-6 at Booth 1223. Visitors may also receive a copy of the ASHP-developed safe handling toolkit at the Equashield booth. Private tours of the Pro, outside of show hours, are available upon request.

About Equashield

Equashield is a leading provider of manual and automated solutions for the compounding and administration of hazardous drugs. Equashield's product suite includes EQUASHIELD II, its flagship Closed System Transfer Device (CSTD), and EQUASHIELD® Pro, the first ever closed system-enabled Automated Pharmacy Compounding System. Equashield's CSTD is clinically-proven to protect healthcare professionals from hazardous drug exposure. EQUASHIELD II covers more routes of exposure than alternative systems and has passed the proposed 2015 alcohol vapor containment protocol from NIOSH, confirming that it can contain the harshest vapors & emissions. Studies have shown Equashield's CSTD as faster to deploy and easier to use than competing systems. Used by hundreds of hospitals and clinics around the world, EQUASHIELD II is CE marked and substantiated by the FDA for preventing microbial ingress for up to seven days.

Follow Equashield on LinkedIn, Twitter and Facebook.

For more information: http://www.equashield.com

Media Contact:Finn Partners for EquashieldNicole Grubnernicole.grubner@finnpartners.com @nicolegrubner+1-929-222-8011

 

 

Cision View original content:http://www.prnewswire.com/news-releases/launch-version-of-equashields-cstd-enabled-automated-pharmacy-compounding-system-to-be-showcased-at-ashp-midyear-meeting-300755768.html

SOURCE Equashield



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store